Genalyte to Offer Patient Testing & Demonstration of its Diagnostic Cloud Lab in San Francisco January 7-11
Founder & CEO Cary Gunn, and President Kevin Lo Available for Meetings, Interviews during J.P. Morgan Healthcare Conference week
SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- Genalyte, Inc. CEO and founder Cary Gunn will publicly debut the company's state of the art diagnostic testing approach for investors and members of the media in San Francisco, January 7-11, 2018.
Visitors to the patient testing lab station will have the opportunity to personally experience the company's comprehensive blood testing service and rapid results delivery. Genalyte's cloud-based lab model delivers reliable diagnostic results in the physician's office in approximately 15 minutes.
Gunn and newly appointed Genalyte President Kevin Lo will be on-site at the testing suite throughout the week, with availability for media briefings and interviews. Investors and media interested in a testing demonstration or meeting, please contact: [email protected]
| DATE: |
Sunday, January 7 – Thursday, January 11 |
| TIME: |
By appointment only |
| MEDIA: |
Testing suite is open to press |
| CONTACT: |
For a testing demonstration or interviews: [email protected] |
About Genalyte
Genalyte's mission is to empower doctors and patients to make better decisions that improve outcomes, lower overall costs, and make the diagnostics experience more effective. We employ a cloud-based laboratory service to bring diagnostic testing into the physician's office. Results are returned in approximately 15 minutes, eliminating the need for separate trips to the lab and waiting for results. For more information, please visit: www.genalyte.com.
SOURCE Genalyte, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article